Related Experiment Video
Updated: Aug 19, 2026

Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes
Published on: January 30, 2019
SMG7 is a 14-3-3-like adaptor in the nonsense-mediated mRNA decay pathway
Noemi Fukuhara1, Judith Ebert, Leonie Unterholzner
1European Molecular Biology Laboratory, Meyerhofstrasse 1, D-69117 Heidelberg, Germany.
Abstract:
In metazoa, regulation of the phosphorylation state of UPF1 is crucial for nonsense-mediated mRNA decay (NMD), a process by which aberrant mRNAs containing nonsense mutations are degraded. UPF1 is targeted for dephosphorylation by three related proteins, SMG5, SMG6, and SMG7. We report here the crystal structure of the N-terminal domain of SMG7. The structure reveals that SMG7 contains a 14-3-3-like domain. Residues that bind phosphoserine-containing peptides in 14-3-3 are conserved at the equivalent positions in SMG7. Mutation of these residues impairs UPF1 binding to SMG7 in vitro and UPF1 recruitment to cytoplasmic mRNA decay foci in vivo, suggesting that SMG7 acts as an adaptor in targeting mRNAs associated with phosphorylated UPF1 for degradation. The 14-3-3 site of SMG7 is conserved in SMG5 and SMG6. These data also imply that the homologous human Est1 might have a 14-3-3 function at telomeres, and that phosphorylation events may be important for telomerase regulation.
Insights
SMG7 protein structure reveals a 14-3-3-like domain crucial for nonsense-mediated mRNA decay (NMD). This finding clarifies SMG7
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Nonsense-mediated mRNA decay (NMD) regulates gene expression by degrading aberrant mRNAs.
- Phosphorylation of UPF1 is a key regulatory step in NMD.
- SMG5, SMG6, and SMG7 proteins dephosphorylate UPF1.
Purpose of the Study:
- To determine the crystal structure of the N-terminal domain of SMG7.
- To elucidate the mechanism by which SMG7 interacts with UPF1.
- To understand the role of SMG7 in NMD.
Main Methods:
- X-ray crystallography to determine SMG7 structure.
- In vitro binding assays to assess UPF1-SMG7 interaction.
- In vivo studies to observe UPF1 recruitment to decay foci.
Main Results:
- The crystal structure of SMG7's N-terminal domain revealed a 14-3-3-like domain.
- Conserved residues in SMG7 mimic 14-3-3 phosphoserine-binding sites.
- Mutating these residues disrupted UPF1 binding in vitro and in vivo.
Conclusions:
- SMG7 functions as an adaptor protein, linking phosphorylated UPF1 to mRNA degradation machinery.
- The 14-3-3-like domain is critical for SMG7's role in NMD.
- Homologous domains in SMG5, SMG6, and potentially human Est1 suggest conserved regulatory roles in mRNA decay and telomere biology.
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nuclear Export of mRNA
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
Pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...

